Smoflipid 20% Injection
Soybean Oil 6g · Triglycerides Medium-Chain 6g +2 more
Prescription medication · Combination
Fresenius Kabi Korea Co., Ltd.
MFDS item code 200604122 · Approved 2006.04.07 · Insurance code 650900340,650900350,650900360
Improvement of nutritional status through the supply of parenteral nutrition (energy, essential fatty acids, etc.)
This medication provides essential nutrition to patients who are unable to receive or insufficiently receive nutrition orally or through the gastrointestinal tract. It is specifically used to improve the nutritional status of patients by supplying energy, essential fatty acids, and omega-3 fatty acids. Therefore, it helps in the recovery of patients who require non-oral nutritional therapy.
Determine the dose and infusion rate according to the patient's capacity to eliminate fat. Administer by intravenous infusion through a central or peripheral vein. Adults: The standard daily dose is 1.0∼2.0 g/kg/day of fat (5∼10 ml/kg/day of this medicine). The recommended infusion rate is 0.125 g/kg/hr of fat (0.63 ml/kg/hr of this medicine), and it should not exceed 0.15 g/kg/hr of fat (0.75 ml/kg/hr of this medicine).
Neonates and infants: The initial dose is 0.5∼1.0 g/kg/day of fat. The daily dose may be gradually increased by 0.5∼1.0 g/kg/day of fat, up to 3.0 g/kg/day of fat (15 ml/kg/day of this medicine); higher doses are not recommended. The infusion rate should not exceed 0.125 g/kg/hr of fat. In premature and low-birth-weight neonates, infusion should be continued for at least 24 hours. When used in infants younger than 2 years, protect the solution from light until administration is complete. If a solution containing this medicine mixed with trace elements and/or vitamins is exposed to light, adverse effects may occur due to the formation of peroxides and other degradation products. Children: Doses exceeding 3 g/kg/day of fat (15 ml/kg/day of this medicine) are not recommended. Gradually increase the daily dose during the first week of administration. The infusion rate should not exceed 0.15 g/kg/hr of fat.
Care should be taken when administering this medicine to premature infants and low-birth-weight infants, as it may elevate free fatty acid levels in the blood. This medicine should not be used in patients allergic to fish, eggs, soybeans, peanut proteins, or any components of this product, in patients with severe hyperlipidemia or extremely poor liver function, in patients with severe bleeding disorders, in patients with extremely poor kidney function, or in patients in acute shock. Care should be taken when administering this medicine to patients who are likely to develop lipid metabolism disorders, such as those with diabetes, renal failure, pancreatitis, liver dysfunction, hypothyroidism, or sepsis. During administration of this medicine, adverse reactions such as blood pressure changes, shortness of breath, loss of appetite, nausea, vomiting, fever, skin rash, and urticaria may occur; any unusual symptoms should be immediately reported to a healthcare provider. Blood triglyceride levels should be regularly monitored to ensure they do not exceed 3 mmol/L, and if elevated, the dosage may need to be reduced or discontinued. This medicine should be prepared under sterile conditions, used immediately after opening, and any unused portion should not be stored for more than 24 hours at 2-8 degrees Celsius. The safety in pregnant or nursing women has not been established, so it should be used cautiously only when necessary. When mixing this medicine with other medications, the mixture should be used immediately, and visual inspection should ensure there is no phase separation in the mixture. During use, regular clinical tests such as blood glucose, liver function, and electrolytes should be performed to detect side effects early. If anaphylactic symptoms such as fever, tremors, skin rashes, or shortness of breath occur during treatment, administration should be stopped immediately, and appropriate treatment should be received. For storage, keep below 25 degrees Celsius and avoid freezing; any opened product should not be reused. Particularly for neonates and infants under 2 years of age, care should be taken to avoid light exposure to the solution during storage and administration.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a sealed container to prevent contact with air, and the storage temperature should be maintained between 1 degree and 25 degrees Celsius. This will help maintain the effectiveness of the medicine.
A milky, homogeneous emulsion contained in a colorless, transparent glass bottle with a rubber stopper suitable for infusion.
50 ml/bottle x 10, 100 ml/bottle x 10, 250 ml/bottle x 10, 500 ml/bottle x 10
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Soybean Oil 6g · Triglycerides Medium-Chain 6g +2 more
Prescription medication · Combination
Fresenius Kabi Korea Co., Ltd.
Soybean Oil 6g · Triglycerides Medium-Chain 6g +2 more
Prescription medication · Combination
Wise Medi Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.